UniProt ID | RIC8A_HUMAN | |
---|---|---|
UniProt AC | Q9NPQ8 | |
Protein Name | Synembryn-A | |
Gene Name | RIC8A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 531 | |
Subcellular Localization | Cytoplasm. Cell membrane. Colocalizes with RIC8A in CA2 hippocampal neurons. Colocalizes with GNAI1 and RGS14 at the plasma membrane (By similarity).. | |
Protein Description | Guanine nucleotide exchange factor (GEF), which can activate some, but not all, G-alpha proteins. Able to activate GNAI1, GNAO1 and GNAQ, but not GNAS by exchanging bound GDP for free GTP. Involved in regulation of microtubule pulling forces during mitotic movement of chromosomes by stimulating G(i)-alpha protein, possibly leading to release G(i)-alpha-GTP and NuMA proteins from the NuMA-GPSM2-G(i)-alpha-GDP complex (By similarity). Also acts as an activator for G(q)-alpha (GNAQ) protein by enhancing the G(q)-coupled receptor-mediated ERK activation.. | |
Protein Sequence | MEPRAVAEAVETGEEDVIMEALRSYNQEHSQSFTFDDAQQEDRKRLAELLVSVLEQGLPPSHRVIWLQSVRILSRDRNCLDPFTSRQSLQALACYADISVSEGSVPESADMDVVLESLKCLCNLVLSSPVAQMLAAEARLVVKLTERVGLYRERSFPHDVQFFDLRLLFLLTALRTDVRQQLFQELKGVRLLTDTLELTLGVTPEGNPPPTLLPSQETERAMEILKVLFNITLDSIKGEVDEEDAALYRHLGTLLRHCVMIATAGDRTEEFHGHAVNLLGNLPLKCLDVLLTLEPHGDSTEFMGVNMDVIRALLIFLEKRLHKTHRLKESVAPVLSVLTECARMHRPARKFLKAQVLPPLRDVRTRPEVGEMLRNKLVRLMTHLDTDVKRVAAEFLFVLCSESVPRFIKYTGYGNAAGLLAARGLMAGGRPEGQYSEDEDTDTDEYKEAKASINPVTGRVEEKPPNPMEGMTEEQKEHEAMKLVTMFDKLSRNRVIQPMGMSPRGHLTSLQDAMCETMEQQLSSDPDSDPD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | AVAEAVETGEEDVIM HHHHHHHHCCHHHHH | 43.21 | - | |
19 | Sulfoxidation | TGEEDVIMEALRSYN HCCHHHHHHHHHHCC | 2.18 | 21406390 | |
24 | Phosphorylation | VIMEALRSYNQEHSQ HHHHHHHHCCHHHCC | 29.32 | 30108239 | |
25 | Phosphorylation | IMEALRSYNQEHSQS HHHHHHHCCHHHCCC | 17.90 | 30108239 | |
30 | Phosphorylation | RSYNQEHSQSFTFDD HHCCHHHCCCCCCCH | 27.11 | 17525332 | |
30 (in isoform 3) | Phosphorylation | - | 27.11 | - | |
32 | Phosphorylation | YNQEHSQSFTFDDAQ CCHHHCCCCCCCHHH | 29.30 | 30108239 | |
32 (in isoform 3) | Phosphorylation | - | 29.30 | 27251275 | |
34 | Phosphorylation | QEHSQSFTFDDAQQE HHHCCCCCCCHHHHH | 31.25 | 30108239 | |
69 | Phosphorylation | HRVIWLQSVRILSRD HEEEEHHHHHHHHCC | 15.93 | 28857561 | |
74 | Phosphorylation | LQSVRILSRDRNCLD HHHHHHHHCCCCCCC | 29.75 | - | |
77 | Ubiquitination | VRILSRDRNCLDPFT HHHHHCCCCCCCCCC | 34.35 | 24816145 | |
172 | Phosphorylation | LRLLFLLTALRTDVR HHHHHHHHHHCHHHH | 26.28 | 24719451 | |
187 | Ubiquitination | QQLFQELKGVRLLTD HHHHHHHHCCEEEEE | 55.39 | 24816145 | |
191 | Ubiquitination | QELKGVRLLTDTLEL HHHHCCEEEEEEEEE | 5.84 | 24816145 | |
193 | Phosphorylation | LKGVRLLTDTLELTL HHCCEEEEEEEEEEE | 31.37 | - | |
193 (in isoform 4) | Phosphorylation | - | 31.37 | 26552605 | |
195 | Phosphorylation | GVRLLTDTLELTLGV CCEEEEEEEEEEECC | 19.52 | - | |
195 (in isoform 4) | Phosphorylation | - | 19.52 | 26552605 | |
199 | Phosphorylation | LTDTLELTLGVTPEG EEEEEEEEECCCCCC | 16.46 | - | |
199 (in isoform 4) | Phosphorylation | - | 16.46 | 26552605 | |
203 | Phosphorylation | LELTLGVTPEGNPPP EEEEECCCCCCCCCC | 17.52 | - | |
203 (in isoform 4) | Phosphorylation | - | 17.52 | 26552605 | |
210 (in isoform 4) | Phosphorylation | - | 36.61 | 26552605 | |
214 (in isoform 4) | Phosphorylation | - | 36.76 | 26552605 | |
217 (in isoform 4) | Phosphorylation | - | 57.90 | 26552605 | |
235 | Phosphorylation | LFNITLDSIKGEVDE HHHCCHHHHCCCCCH | 29.34 | 28064214 | |
243 | Ubiquitination | IKGEVDEEDAALYRH HCCCCCHHHHHHHHH | 48.78 | 21890473 | |
279 | Ubiquitination | HGHAVNLLGNLPLKC CCHHHHHCCCCCCCH | 3.45 | 24816145 | |
299 | Ubiquitination | TLEPHGDSTEFMGVN HCCCCCCCCCCCCCC | 34.13 | 21890473 | |
324 | Phosphorylation | LEKRLHKTHRLKESV HHHHHHHHHHCHHHH | 11.07 | - | |
326 | Phosphorylation | KRLHKTHRLKESVAP HHHHHHHHCHHHHHH | 53.32 | 32142685 | |
328 | Ubiquitination | LHKTHRLKESVAPVL HHHHHHCHHHHHHHH | 48.15 | - | |
330 | Phosphorylation | KTHRLKESVAPVLSV HHHHCHHHHHHHHHH | 23.22 | 28857561 | |
331 | Phosphorylation | THRLKESVAPVLSVL HHHCHHHHHHHHHHH | 7.97 | 32142685 | |
339 | Phosphorylation | APVLSVLTECARMHR HHHHHHHHHHHHCCC | 27.19 | 30576142 | |
340 | Ubiquitination | PVLSVLTECARMHRP HHHHHHHHHHHCCCH | 23.24 | 33845483 | |
341 | Glutathionylation | VLSVLTECARMHRPA HHHHHHHHHHCCCHH | 2.16 | 22555962 | |
346 (in isoform 2) | Ubiquitination | - | 19.75 | 21890473 | |
352 (in isoform 1) | Ubiquitination | - | 5.15 | 21890473 | |
352 (in isoform 4) | Ubiquitination | - | 5.15 | - | |
353 | Malonylation | RPARKFLKAQVLPPL CHHHHHHHCCCCCCC | 39.65 | 32601280 | |
353 | Ubiquitination | RPARKFLKAQVLPPL CHHHHHHHCCCCCCC | 39.65 | 33845483 | |
357 | Ubiquitination | KFLKAQVLPPLRDVR HHHHCCCCCCCCCCC | 2.10 | 21890473 | |
372 | Sulfoxidation | TRPEVGEMLRNKLVR CCHHHHHHHHHHHHH | 3.33 | 21406390 | |
379 | Ubiquitination | MLRNKLVRLMTHLDT HHHHHHHHHHHHCCH | 29.22 | 23000965 | |
382 | Phosphorylation | NKLVRLMTHLDTDVK HHHHHHHHHCCHHHH | 24.71 | 28857561 | |
389 | Ubiquitination | THLDTDVKRVAAEFL HHCCHHHHHHHHHHH | 43.92 | 24816145 | |
392 | Phosphorylation | DTDVKRVAAEFLFVL CHHHHHHHHHHHHHH | 12.81 | 32142685 | |
393 | Ubiquitination | TDVKRVAAEFLFVLC HHHHHHHHHHHHHHH | 12.76 | 24816145 | |
395 | Ubiquitination | VKRVAAEFLFVLCSE HHHHHHHHHHHHHCC | 5.71 | 24816145 | |
402 (in isoform 2) | Ubiquitination | - | 55.55 | 21890473 | |
408 (in isoform 1) | Ubiquitination | - | 3.35 | 21890473 | |
408 (in isoform 4) | Ubiquitination | - | 3.35 | - | |
409 | Ubiquitination | ESVPRFIKYTGYGNA CCCCCHHHHCCCCCH | 33.76 | 23000965 | |
413 | Ubiquitination | RFIKYTGYGNAAGLL CHHHHCCCCCHHHHH | 10.21 | 21890473 | |
415 | Ubiquitination | IKYTGYGNAAGLLAA HHHCCCCCHHHHHHH | 20.38 | 21890473 | |
415 (in isoform 3) | Ubiquitination | - | 20.38 | 21890473 | |
434 | Phosphorylation | AGGRPEGQYSEDEDT CCCCCCCCCCCCCCC | 36.60 | 18669648 | |
435 | Phosphorylation | GGRPEGQYSEDEDTD CCCCCCCCCCCCCCC | 25.53 | 22167270 | |
436 | Phosphorylation | GRPEGQYSEDEDTDT CCCCCCCCCCCCCCH | 30.59 | 19664994 | |
440 | Phosphorylation | GQYSEDEDTDTDEYK CCCCCCCCCCHHHHH | 63.30 | 32142685 | |
441 | Phosphorylation | QYSEDEDTDTDEYKE CCCCCCCCCHHHHHH | 38.46 | 19664994 | |
441 (in isoform 3) | Phosphorylation | - | 38.46 | - | |
442 | Phosphorylation | YSEDEDTDTDEYKEA CCCCCCCCHHHHHHH | 65.56 | 32142685 | |
442 (in isoform 3) | Phosphorylation | - | 65.56 | 21406692 | |
443 | Phosphorylation | SEDEDTDTDEYKEAK CCCCCCCHHHHHHHH | 32.59 | 19664994 | |
445 | Phosphorylation | DEDTDTDEYKEAKAS CCCCCHHHHHHHHHH | 61.67 | 32142685 | |
446 | Phosphorylation | EDTDTDEYKEAKASI CCCCHHHHHHHHHHC | 19.55 | 23401153 | |
447 | Phosphorylation | DTDTDEYKEAKASIN CCCHHHHHHHHHHCC | 49.50 | 32142685 | |
447 (in isoform 3) | Phosphorylation | - | 49.50 | 21406692 | |
449 (in isoform 3) | Phosphorylation | - | 14.46 | 21406692 | |
450 | Ubiquitination | TDEYKEAKASINPVT HHHHHHHHHHCCCCC | 43.70 | 33845483 | |
452 | Phosphorylation | EYKEAKASINPVTGR HHHHHHHHCCCCCCC | 23.38 | 18669648 | |
452 (in isoform 3) | Phosphorylation | - | 23.38 | - | |
454 | Ubiquitination | KEAKASINPVTGRVE HHHHHHCCCCCCCCC | 23.61 | 33845483 | |
456 | Ubiquitination | AKASINPVTGRVEEK HHHHCCCCCCCCCCC | 8.40 | 33845483 | |
457 | Phosphorylation | KASINPVTGRVEEKP HHHCCCCCCCCCCCC | 22.11 | 21406692 | |
458 (in isoform 3) | Phosphorylation | - | 31.69 | 21406692 | |
468 | Sulfoxidation | EEKPPNPMEGMTEEQ CCCCCCCCCCCCHHH | 9.87 | 30846556 | |
471 | Sulfoxidation | PPNPMEGMTEEQKEH CCCCCCCCCHHHHHH | 2.44 | 30846556 | |
472 | Phosphorylation | PNPMEGMTEEQKEHE CCCCCCCCHHHHHHH | 47.42 | 29083192 | |
481 | Sulfoxidation | EQKEHEAMKLVTMFD HHHHHHHHHHHHHHH | 2.92 | 30846556 | |
485 | Phosphorylation | HEAMKLVTMFDKLSR HHHHHHHHHHHHHCC | 23.66 | - | |
486 | Sulfoxidation | EAMKLVTMFDKLSRN HHHHHHHHHHHHCCC | 2.97 | 21406390 | |
489 | Malonylation | KLVTMFDKLSRNRVI HHHHHHHHHCCCCCC | 36.78 | 26320211 | |
489 | Ubiquitination | KLVTMFDKLSRNRVI HHHHHHHHHCCCCCC | 36.78 | 23000965 | |
491 | Phosphorylation | VTMFDKLSRNRVIQP HHHHHHHCCCCCCCC | 33.00 | 28348404 | |
493 | Ubiquitination | MFDKLSRNRVIQPMG HHHHHCCCCCCCCCC | 38.91 | 23000965 | |
495 | Ubiquitination | DKLSRNRVIQPMGMS HHHCCCCCCCCCCCC | 5.64 | 23000965 | |
495 (in isoform 3) | Ubiquitination | - | 5.64 | - | |
497 (in isoform 3) | Phosphorylation | - | 21.04 | 27251275 | |
501 | Phosphorylation | RVIQPMGMSPRGHLT CCCCCCCCCCCHHCH | 3.97 | 18669648 | |
502 | Phosphorylation | VIQPMGMSPRGHLTS CCCCCCCCCCHHCHH | 13.01 | 25159151 | |
506 | Phosphorylation | MGMSPRGHLTSLQDA CCCCCCHHCHHHHHH | 27.49 | 32142685 | |
508 | Phosphorylation | MSPRGHLTSLQDAMC CCCCHHCHHHHHHHH | 23.01 | 18669648 | |
508 (in isoform 3) | Phosphorylation | - | 23.01 | 24719451 | |
509 | Phosphorylation | SPRGHLTSLQDAMCE CCCHHCHHHHHHHHH | 30.32 | 21406692 | |
517 | Phosphorylation | LQDAMCETMEQQLSS HHHHHHHHHHHHHHC | 22.53 | 25137130 | |
522 | Phosphorylation | CETMEQQLSSDPDSD HHHHHHHHHCCCCCC | 5.45 | 18669648 | |
523 | Phosphorylation | ETMEQQLSSDPDSDP HHHHHHHHCCCCCCC | 28.49 | 17081983 | |
524 | Phosphorylation | TMEQQLSSDPDSDPD HHHHHHHCCCCCCCC | 62.85 | 17081983 | |
527 | Phosphorylation | QQLSSDPDSDPD--- HHHHCCCCCCCC--- | 71.33 | 18669648 | |
528 | Phosphorylation | QLSSDPDSDPD---- HHHCCCCCCCC---- | 57.33 | 11230166 | |
529 (in isoform 3) | Phosphorylation | - | 59.78 | 27251275 | |
530 (in isoform 3) | Phosphorylation | - | 53.84 | 27251275 | |
534 (in isoform 3) | Phosphorylation | - | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RIC8A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RIC8A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RIC8A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GNA13_HUMAN | GNA13 | physical | 12509430 | |
GNAQ_HUMAN | GNAQ | physical | 12509430 | |
GNAI3_HUMAN | GNAI3 | physical | 12509430 | |
GNAI2_HUMAN | GNAI2 | physical | 12509430 | |
GNAO_HUMAN | GNAO1 | physical | 12509430 | |
GNAI1_HUMAN | GNAI1 | physical | 12509430 | |
XPO1_HUMAN | XPO1 | physical | 21988832 | |
GNAQ_HUMAN | GNAQ | physical | 16629901 | |
APEX1_HUMAN | APEX1 | physical | 22863883 | |
MSHR_HUMAN | MC1R | physical | 22863883 | |
PLCG1_HUMAN | PLCG1 | physical | 22863883 | |
PYGB_HUMAN | PYGB | physical | 22863883 | |
NUTM1_HUMAN | NUTM1 | physical | 25416956 | |
SPAG5_HUMAN | SPAG5 | physical | 28514442 | |
DCTN4_HUMAN | DCTN4 | physical | 28514442 | |
DCTN3_HUMAN | DCTN3 | physical | 28514442 | |
DCTN6_HUMAN | DCTN6 | physical | 28514442 | |
DCTN5_HUMAN | DCTN5 | physical | 28514442 | |
DCTN1_HUMAN | DCTN1 | physical | 28514442 | |
ARP10_HUMAN | ACTR10 | physical | 28514442 | |
ACTY_HUMAN | ACTR1B | physical | 28514442 | |
MTCH1_HUMAN | MTCH1 | physical | 28514442 | |
ACTZ_HUMAN | ACTR1A | physical | 28514442 | |
DCTN2_HUMAN | DCTN2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436; THR-441 ANDSER-502, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-435 AND SER-436, ANDMASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436 AND THR-441, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436; THR-441; SER-502;SER-523; SER-524 AND SER-528, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436; THR-441 ANDSER-502, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND MASSSPECTROMETRY. |